PhotoMedex (Nasdaq: PHMD) reported earnings on May 8. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q1), PhotoMedex met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded. GAAP earnings per share grew significantly.

Margins grew across the board.

Revenue details
 PhotoMedex booked revenue of $57.2 million. The five analysts polled by S&P Capital IQ foresaw revenue of $58.0 million on the same basis. GAAP reported sales were 14% higher than the prior-year quarter's $50.3 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.34. The five earnings estimates compiled by S&P Capital IQ predicted $0.29 per share. GAAP EPS of $0.34 for Q1 were 31% higher than the prior-year quarter's $0.26 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 79.3%, 160 basis points better than the prior-year quarter. Operating margin was 16.8%, 260 basis points better than the prior-year quarter. Net margin was 12.6%, 290 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $59.1 million. On the bottom line, the average EPS estimate is $0.35.

Next year's average estimate for revenue is $241.2 million. The average EPS estimate is $1.36.

Investor sentiment
 The stock has a one-star rating (out of five) at Motley Fool CAPS, with 13 members out of 20 rating the stock outperform, and seven members rating it underperform. Among nine CAPS All-Star picks (recommendations by the highest-ranked CAPS members), four give PhotoMedex a green thumbs-up, and five give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on PhotoMedex is buy, with an average price target of $21.38.

Is PhotoMedex the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.